Literature DB >> 28905244

Bioresorbable vascular scaffold implantation to bail out nail gun injury in ST-segment myocardial infarction.

Torsten Schütz1, Friedrich P Krönig2, Christoph Karmeinsky3, Oliver Weingärtner4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28905244     DOI： 10.1007/s00392-017-1160-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  10 in total

1.  Images in cardiovascular medicine. Direct nail injury to the heart without functional or hemodynamic compromise.

Authors:  Georgios P Georghiou; Einat Birk; Moshe Nili; Michael Stein; Bernardo A Vidne; Eldad Erez
Journal:  Circulation       Date:  2003-04-15       Impact factor: 29.690

2.  Nail gun may cause heart injury: a young adult's misadventure.

Authors:  Mouhcine Madani; Mohammed Drissi; Mohamed Rida Ajaja; Maatir Rifai; El Mehdi Moutaouakkil; Younes Cheikhaoui; Anas Slaoui
Journal:  Int Emerg Nurs       Date:  2011-08-02       Impact factor: 2.142

3.  Effect of a dihydropyridine-type calcium channel blocker on vascular remodeling after experimental balloon angioplasty.

Authors:  Alexander F Kranzhöfer; Oliver Weingärtner; Martin Oberhoff; Karl R Karsch
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2011-01

4.  Accidental nail gun injuries to the heart: diagnostic, treatment, and epidemiological considerations.

Authors:  L Nölke; P Naughton; C Shaw; J Hurley; A E Wood
Journal:  J Trauma       Date:  2005-01

5.  Penetrating cardiac nail gun injury.

Authors:  C S Carr; S Alkhafaji; A M Alkhulaifi
Journal:  Emerg Med J       Date:  2008-05       Impact factor: 2.740

6.  Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.

Authors:  Patrick W Serruys; Yuki Katagiri; Yohei Sotomi; Yaping Zeng; Bernard Chevalier; René J van der Schaaf; Andreas Baumbach; Pieter Smits; Nicolas M van Mieghem; Antonio Bartorelli; Paul Barragan; Anthony Gershlick; Ran Kornowski; Carlos Macaya; John Ormiston; Jonathan Hill; Irene M Lang; Mohaned Egred; Jean Fajadet; Maciej Lesiak; Stephan Windecker; Robert A Byrne; Lorenz Räber; Robert-Jan van Geuns; Gary S Mintz; Yoshinobu Onuma
Journal:  J Am Coll Cardiol       Date:  2017-07-04       Impact factor: 24.094

7.  Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.

Authors:  Fumiyuki Otsuka; Erica Pacheco; Laura E L Perkins; Jennifer P Lane; Qing Wang; Marika Kamberi; Michael Frie; Jin Wang; Kenichi Sakakura; Kazuyuki Yahagi; Elena Ladich; Richard J Rapoza; Frank D Kolodgie; Renu Virmani
Journal:  Circ Cardiovasc Interv       Date:  2014-06-03       Impact factor: 6.546

8.  Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox.

Authors:  G Pasterkamp; A H Schoneveld; A C van der Wal; C C Haudenschild; R J Clarijs; A E Becker; B Hillen; C Borst
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

9.  Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.

Authors:  Georg Fuernau; Karl Fengler; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Christian Jung; Michael Böhm; Janine Pöss; Ruth H Strasser; Steffen Schneider; Taoufik Ouarrak; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2016-07-04       Impact factor: 5.460

10.  Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios.

Authors:  Milosz Jaguszewski; Jelena-Rima Ghadri; Manuel Zipponi; Dana Roxana Bataiosu; Johanna Diekmann; Verena Geyer; Catharina Anna Neumann; Mia Aurelia Huber; Christian Hagl; Paul Erne; Thomas F Lüscher; Christian Templin
Journal:  Clin Res Cardiol       Date:  2014-08-31       Impact factor: 5.460
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.